Introduction
To date, approximately 150 nonsyndromic hearing impairment (NSHI) genes have been localized, and about 90 of them display autosomal recessive (AR) inheritance. Fourty-one genes have been identified for ARNSHI (see also the Hereditary Hearing Loss Homepage). The discovery of new NSHI genes should improve our understanding of the mechanism of hearing as well as aid in the development of diagnostic and therapeutic interventions for hearing impairment (HI).
This article describes the mapping of the DFNB90 locus to chromosome 7p22.1-p15.3 in a multigenerational consanguineous Pakistani family with ARNSHI. Although already seven ARNSHI loci have been mapped to chromosome 7 for which three genes have been identified, SLC26A5 [1] (MIM 60493), SLC26A4 [2] (MIM 605646) and HGF [3] (MIM 142409), there is no overlap between this new locus and previously reported loci.
Materials and Methods
The Institutional Review Boards of the Quaid-I-Azam University and the Baylor College of Medicine and Affiliated Hospitals approved the research protocol prior to study initiation. Informed consent was obtained from all family members who participated in this study. Family 4437 is a multigenerational consanguineous kindred which displays clear evidence of ARNSHI ( fig. 1 ). The ARNSHI in this family is bilateral, symmetric and prelingual. An audiogram from individual IV-1 displays severe-to-profound impairment at all frequencies ( fig. 2 ) . Careful physical examination, including Romberg testing, gait assessment and fundoscopy, were performed to rule out vestibular or syndromic features. Perinatal, maternal and personal medical history regarding infections, ototoxic drug use, traumas and noise exposure did not indicate a possible environmental cause for HI.
Venous blood was obtained from ten family members, including four individuals who are hearing-impaired. Genomic DNA was extracted following a standard protocol [4] . A whole genome scan was carried out at the Center for Inherited Disease Research (CIDR) using the Illumina HumanLinkage-12 panel which contains 6,090 SNP marker loci.
The genotype data were screened for Mendelian incompatibilities using PEDCHECK [5] , while MERLIN [6] was used to assess the data for occurrence of double recombination events over short genetic distances, which are most likely due to genotyping error. MLINK of the FASTLINK package [7] was used to perform a twopoint linkage analysis, while ALLEGRO1.2c [8] was used for a multipoint linkage analysis. An AR mode of inheritance with complete penetrance and a disease allele frequency of 0.001 were used in the analysis. Marker allele frequencies were estimated from observed and reconstructed genotypes of founders from pedigree 4437 and 50 additional Pakistani families that underwent a genome scan at the same time at the CIDR. For the multipoint analysis, genetic map distances were based on the Build 36 version of the Rutgers combined linkage-physical map of the human genome [9] . For those SNP loci which were not included on the Rutgers map, the sequence-based physical map (Build 36) was used as a reference to determine the physical positions of SNP marker loci and then interpolation was used to determine the genetic map distance.
In addition to carrying out a multipoint linkage analysis using ALLEGRO1.2c, a linkage analysis was also carried out using MERLIN, due to concerns that the multipoint LOD score might be inflated due to intermarker linkage disequilibrium (LD) . MERLIN was used to analyze clusters of markers that had no intermarker recombination using haplotype frequencies that were estimated from family 4437 and 50 additional families which were genotyped at the same time. Haplotype reconstruction was performed using SIMWALK2 [10, 11] .
Primers were designed to cover the exons and 5 promoter region of eight genes (ACTB , BZW , OCM , MACC1 , NXPH1 , PRPS1L1 , RAC1 and RPA3) using Primer3 software [12] . DNA samples from one hearing (III-1) and two HI (IV-3 and IV-6) pedigree members ( fig. 1 ) were diluted, PCR-amplified, then purified with ExoSAP-IT (USB Corp., Cleveland, Ohio, USA). Sequencing of exons and splice site regions was performed with the BigDye Terminator v3.1 Cycle Sequencing Kit and Applied Biosystems 3730 DNA Analyzer (Applera Corp., Foster City, Calif., USA). The DNA sequences were assembled and analyzed through the Sequencher software V4.9 (Gene Codes Corp., Ann Arbor, Mich., USA).
Results
No genotyping errors were detected through the occurrence of Mendelian inconsistencies or double recombination events occurring over short genetic map distances. A maximum two-point LOD score of 2.5 ( = 0) was observed at marker rs957960 (chromosome 7: 18.84 Mb) ( table 1 ). Using ALLEGRO1.2c, a maximum multipoint LOD score of 4.0 was obtained for 20 marker loci located on chromosome 7 (see table 1 ). Incorporating LD in the analysis using MERLIN did not change the results. The 3-unit support interval, which spans 26.5 cM, lies between markers rs1553960 (4.87 Mb) and rs206198 (20.34 Mb) and contains 15.47 Mb of sequence ( table 1 ) .
The region of homozygosity overlaps with the 3-unit support interval. A recombination event between SNP markers rs1553960 and rs1468996 was observed in the affected child IV-4, which delimited the upper boundary of the region of homozygosity. The lower boundary of the region of homozygosity is delimited by the recombination event between SNP markers rs714392 and rs206198 in child IV-5. The region of homozygosity resides between the markers rs1553960 (4.87 Mb) and rs206198 (20.34 Mb; fig. 1 ). The locus DFNB90 was designated by the HUGO Nomenclature Committee.
Within the region of homozygosity, there are 72 genes which include hypothetical proteins. No functional sequence variants were identified in the eight sequenced candidate genes.
Discussion
Six ARNSHI loci have been mapped to the long arm of chromosome 7 (7q): DFNB4 (7q31) [13] , DFNB13 (7q34-q36) [14] , DFNB14 (7q31) [15] , DFNB17 (7q31) [16] , DFNB39 (7q11.22-q21.12) [17] , and DFNB61 (7q22.1) [1] . Extending from the short to the long arm of chromosome 7 lies DFNB44 (7p14.1-q11.22) [18] , which is 17.2 Mb centromeric to DFNB90 ( fig. 3 ). For these ARNSHI loci, only the genes SLC26A5 for DFNB61 [1] , SLC26A4 for DFNB4 [2] and HGF for DFNB39 [3] have been identified. Additionally, on chromosome 7p lies the autosomal dominant (AD) locus DFNA5, which is centromeric to DFNB90 by 4.4 Mb, and on chromosome 7q is DFNA50 [19] , which lies between DFNB17 and DFNB13. The gene for DFNA5 has been identified and bears the same name, DFNA5 [20] . For DFNA50, the microRNA miR-96 [21] was shown to be responsible for progressive ADNSHI. Mapping of ARNSHI in family 4437 to the 7p22.1-p15.3 makes 1  1  1  2  2  2  1  1  1  1  1  2  2  2  2  2  2  2  1  2  1  2  1   2  2  2  2  2  1  2  2  2  1  1  1  2  1  2  1  1  1  2  1  2  1  1  2  1   2  2  2  2  2  1  2  2  2  1  1  1  2  1  2  1  1  1  2  1  2  1  1  2  1   1  1  1  2  2  1  1  1  1  1  1  2  1  2  1  2  1  1  2  2  2  2  1  1  1   2  2  2  2  2  1  2  2  2  1  1  1  2  1  2  1  1  1  2  1  2  1  1  2 1  1  2  2  2  2  2  2  2  1  2  1  1  2   rs1543985  rs1553960  rs1468996  rs4560  rs1299548  rs1882600  rs37995  rs1558557  rs1032873  rs1013719  rs1012123  rs12666416  rs2908740  rs769111  rs6460985  rs1367781  rs917440  rs726395  rs2030972  rs1723804  rs1375237  rs957960  rs714392  rs206198  rs4142216   rs1543985  rs1553960  rs1468996  rs4560  rs1299548  rs1882600  rs37995  rs1558557  rs1032873  rs1013719  rs1012123  rs12666416  rs2908740  rs769111  rs6460985  rs1367781  rs917440  rs726395  rs2030972  rs1723804  rs1375237  rs957960  rs714392  rs206198  rs4142216   I   II   III   IV   1 DFNB90 the tenth NSHI locus to be localized to chromosome 7.
Among the eight genes which were sequenced within the DFNB90 region, the PRPS1L1 gene encodes a highly homologous protein Phosphoribosyl Pyrophosphate Synthetase 1-Like 1 (MIM 611566) to the two subunits of Phosphoribosyl Pyrophosphate Synthetase 1 ( PRPS1 ; MIM 311850) . PRPS1 is the cause of X-linked NSHI ( DFN2) [22] ; Charcot-Marie-Tooth disease 5 [23] , a syndromic form of auditory and optic neuropathy; Arts syndrome [24] , which is characterized by mental retardation, motor problems, optic atrophy and hearing impairment; and phosphoribosyl pyrophosphate synthetase superactivity [25] , for which the phenotype includes gout from hyperuricemia and neurodevelopmental abnormalities including sensorineural deafness.
The Metastasis-Associated gene in Colon Cancer 1 ( MACC1 ; MIM 612646) is believed to be a key regulator of the hepatocyte growth factor (HGF ; MIM 142409) and the HGF receptor ( HGFR or MET ; MIM164860) pathway [26] . HGF was reported to be the gene responsible for the ARNSHI locus DFNB39 [3] .
Six of the sequenced genes (Actin, Beta ( ACTB ; MIM 102630), Basic Leucine Zipper and W2 Domains 2 (BZW2) , Neuroxophilin ( NXPH1 ; MIM 604639), Oncomodulin ( OCM ; MIM 164795), Replication Protein A3 ( RPA3 ; MIM 179837) and RAS-related C3 botulinum toxin substrate 1 ( RAC1 ; MIM 602048)) have all been shown to be expressed in the fetal human cochlea [27] . Additionally, the ACTB gene was reported to cause a form of juvenile-onset dystonia that is accompanied by sensorineural hearing loss [28, 29] ACTB gene is also 93% identical to Actin, Gamma 1 [30] ( ACTG1 ; MIM 102560) which is the cause of one form of ADNSHI.
The OCM [31] gene is exclusively expressed in outer hair cells of the cochlea and also in the apical inner hair cells. In the outer hair cells, protein expression was observed in the nucleus, cytoplasm and cuticular plate, but not in the stereocilia.
The identification of the DFNB90 gene should provide additional insight into the genetic etiology of ARNSHI and the mechanism of hearing.
